On the recordJuly 28, 2021
So if FDA had a similar authority for a conditional approval pathway, would that give the FDA more flexibility in getting potentially promising therapies to dying patients sooner?
Source
congress.govEditor's note · Context
Eshoo questions the FDA's ability to expedite drug approvals for critical patients.
Share
More from Anna Eshoo
Apr 18, 2023
I introduced the Community Broadband Act, which simply prohibits State laws that ban or restrict community broadband.
Sep 23, 2024
Today, the House will vote on my legislation, H.R. 3433, the Give Kids a Chance Act. My thanks to Reps. Michael McCaul (R-TX) and Gus Bilirakis (R-FL), the chairwoman of the Energy and Commerce Committee Cathy McMorris Rodgers (R-WA) and…
Apr 25, 2023
The Medicaid Value-Based Payments for Patients Act will codify a CMS rule to help ensure Medicaid enrollees have access to breakthrough gene therapies.
Apr 25, 2023
I think that, you know, to a person--well, maybe not to a--well, just--I am getting myself in a little trouble here.
Other voices in this conversation
